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ABSTRACT 
Objective 
To assess the impact of relaxed asthma recruitment standards adopted by the Australian 
Defence Force (ADF) in 2007. 
Methods 
A retrospective audit was conducted on clinical and administrative data for recruits, with 
and without mild asthma, in their first year of service.  
Results 
There was no evidence that mild asthmatics experienced worse outcomes than non-
asthmatic recruits.  Mild asthmatics had fewer illnesses and restricted duty days and were 
less costly compared to other recruits.  There was no difference in the rate of discharge 
(attrition) between those with and without mild asthma. 
Conclusions 
The revised recruitment standards for asthma in the ADF have not resulted in unanticipated 
medical or administrative costs to the organisation. Health and administrative outcomes 
differed little between mild asthmatics and non-asthmatic recruits in their first twelve 
months of service.  
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INTRODUCTION 
In 2007, the Australian Defence Force (ADF) revised its recruitment standards in relation to 
asthma to determine whether there was potential to increase recruitment into the ADF by 
safely enlisting personnel with intermittent or mild persistent asthma.  Previously, 
applicants who had a history of asthma within three years of their application were not 
permitted to enlist (ADF Protocol 701).  Those general recruits who had a history of asthma 
more than three years prior to their application, but not in the previous three years, could 
enlist without necessarily undergoing further objective assessment.  The ADF relaxed the 
medical criteria for individuals with mild asthma (within the last three years) who wished to 
join the ADF  based on clinical evidence that supported an amendment to the standards for 
asthma [1].  Everyone with asthma who joins the ADF undergoes bronchial provocation 
testing to confirm the diagnosis and treatment requirements. 
Accepting recruits with asthma into the ADF is not without risk.  It is possible that for some 
individuals, the physical and mental stress involved in training and active duty could 
exacerbate or re-establish symptoms of asthma. During regular service, military personnel 
may be exposed to various environmental stimuli or physical conditions that can exacerbate 
or cause asthma. These include: exposure to dust, humid, freezing, or smoky environments; 
exposure to chemicals and biological agents; physical demands; lack of sleep; emotional 
stress (i.e. from being in a hostile environment, unpredictable environment), crowded living 
conditions which can lead to increased risk of spread of infection; use of restrictive 
protective masks (can make breathing difficult and restricts use of medications); and 
possible restriction of readily available asthma medications and treatments [2 3]. For the 
ADF, there are risks of increased resources required for health care, implications for duty of 
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care, the impact on operational readiness, and the wastage of time and resources in training 
recruits who are subsequently discharged.   
After the recommendations to relax the ADF recruitment standards for asthma were 
adopted in 2007, it was considered imperative to validate them.  It was also important to 
determine whether the health outcomes of mild asthmatics recruited into the ADF were 
significantly different from non-asthmatics.  This information would allow the ADF to 
determine whether they should retain or further review the revised medical recruitment 
standards.  
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METHODS 
Data collection 
This study was approved by the Australian Defence Health Research Ethics Committee and 
the Human Research Ethics Committee at The University of Queensland.  This was a 
retrospective cohort study of ADF personnel from Army, Navy, and Air Force service 
branches.  Reservists were not included in the study.   
Recruits with a history of asthma, were assessed on enlistment as to whether they met the 
entry requirement for the ADF [4].  Those with a diagnosis and/or management of asthma 
within the previous 3 years underwent spirometry testing (performed by ADF) and Bronchial 
Provocation Testing (BPT).  The spirometry uses FEV1 as an indicator of asthma severity and 
the best of three attempts is recorded.  The BPT uses nebulized methacholine or histamine, 
which provoke narrowing of the airwaves. Asthmatics react to lower doses of these drugs. If 
the spirometry was normal (FEV1 greater than or equal to 80% predicted), the BPT was 
negative (non-reactive) and either no or only low dose asthma medication was required, 
members were eligible for entry into the ADF. 
Low dose medications are defined as daily doses of: 
•80–160 mcg ciclesonide  
•100–200 mcg beclomethasone  
•100–200 mcg of fluticasone, or 
•200–400 mcg budesonide. [4] 
The study comprised three cohorts assigned using the information and testing undertaken 
in the recruitment process: (1) Previous mild asthma were 99 new recruits with a with a 
history of asthma within the last three years, but no current asthma symptoms (normal 
sprometry and negative BPT) or asthma medication; (2) Current mild asthma were 221 new 
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recruits with current mild asthma (normal sprometry and negative BPT) who were taking 
low dose asthma medication; (3) No asthma were 220 new recruits who had no history of 
asthma ever or had no asthma symptoms within the past three years. 
The Department of Defence provided a list of new recruits (for the years 2007 and 2011) 
who were identified as having Previous mild asthma or Current mild asthma from 
recruitment records using the criteria outlined.  The control group (No asthma) was 
generated by CMVH by selecting a random sample from personnel entering the ADF 
between 2006 and 2011 stratified by the season of the year in which they enlisted.  The 
control group was selected to be the same size as the Current asthma group. 
Data were collected only during the first 12 months of training, or up until the date of 
discharge (which ever occurred earliest).  Not all personnel joined the ADF at the same time, 
thus the study included personnel who joined the ADF between 2006 and 2011 (from 2007 
for the current mild asthma or previous asthma cohorts).  Individuals were eligible for 
inclusion in the current mild asthma or previous asthma cohorts if they passed the 
requirements for entry into the ADF and for whom a history of asthma, current or within the 
previous 3 years, was recorded.  Bronchial provocation testing confirmed diagnosis and 
treatment requirements in the asthma cohorts.  Personal medical records were then 
retrieved for these individuals and those in the no asthma comparison group.  
For the people included in the study we obtained a file containing their ADF Central Medical 
Record. We also received information on health and administrative outcomes from the 
Directorate of Workforce Information. Data relating to illnesses (based on the number of 
presentations to medical practitioners on separate days, excluding injuries), restricted duty 
days and lost full days were obtained from ADF Central Medical Records.  Data relating to 
administrative outcomes (e.g. restricted work days, sick leave, all-cause discharge) were 
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obtained from Directorate of Workforce Information within the ADF.  These two sources of 
data provided a comprehensive record of the health of new recruits for the first year of 
service. 
Economic modelling  
To calculate the economic cost of lost productivity, estimated daily wage rates were 
multiplied by the number of days that the individuals were unable to perform ‘normal 
duties’ as a result of illness. The time lost from normal duties was classified into three 
categories: the number of days the ADF member was placed on restricted duties (restricted 
work days), the number of days they were unable to perform any duties (full days off work), 
and the number of days the ADF member was an inpatient in hospital (hospital days).  
Productivity losses were then compared between the Current mild asthma, Previous mild 
asthma, and No asthma cohorts. 
The methods used in this economic analysis were comparable to those used in a similarly 
designed study which assessed the cost associated with different BMI categories.  A 
comprehensive description of the methods and the assumptions applied are detailed in the 
economic modelling section of that paper [5].  A summary of the methods used is provided 
in this section. 
To calculate estimates of daily wage rates, base salaries for permanent ADF trainees as of 
November 2009 were used [5], which was close to the midpoint of the range of the years of 
enlistment (2006 to 2011). The estimated wages per day for injured ADF trainees were used 
to calculate the cost of lost full days of work (including costs of hospital days). For restricted 
duty days, it was assumed that ADF trainees placed on restricted duty days were able to 
perform 50% of their normal duties. Therefore, 50% of their wages per day were used as the 
cost of restricted duty days.  All costs are presented in Australian dollars. 
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Outcome measures 
The number of illnesses per person was assessed as an outcome of interest. Absenteeism, 
calculated as the number of full days off work (including hospital days) and restricted work 
days, and the associated costs of these events was also compared between the three 
cohorts.  The other outcomes assessed were the cost of medication and asthma 
prescriptions in each cohort and the rate of attrition (number of discharges) out of the ADF 
within the first 12 months of service. 
The cost of days in hospital referred to the costs associated with the hospital stay estimated 
from the National Hospital Cost Collection Cost Report Round 12 (2007-2008) September 
2009 [6]. This cost was estimated to be $1,324 per day [5].   
Data analysis 
Data for illness, restricted duty days, lost full days, training outcomes and medical 
classification were compared between the three cohorts using negative binomial regression. 
Logistic regression compared dichotomous health outcomes between the asthma cohorts.  
The mean number of illnesses was compared using a negative binominal model.  These 
models were adjusted for age (1519, 2024, 2529, 30+), sex, and Service (i.e. Army, Navy, 
Air Force). Counts of illnesses and days absent as well as cost data were also compared 
using the Mann-Whitney-U-Test (non-parametric). This particular test was unadjusted. The 
comparison of medians and distributions was used because outliers had less influence on 
the outcome of these tests.  
A survival analysis was performed to compare and predict discharge rates between the 
three cohorts. For this analysis, recruitment date, discharge date and cohort group were 
used. The follow up period was for one year. 
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Statistical analyses were performed using SAS version 9.2 [7] and Stata 10.0 [8]. Statistical 
significance was set at  = 0.05. Data are presented as totals, mean ( SD) and medians 
(range).  
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RESULTS 
The distribution of sex, Service, and age differed between the three cohorts (Table 1) and 
therefore these characteristics were adjusted for in the statistical models.  The rank 
distribution was similar between the three cohorts. All ADF personnel in the study were new 
recruits, with approximately 20% entering at the level of officer.  The overall mean age of 
ADF personnel in the study was 22.8 years (SD = 5.1).   
Illnesses were less prevalent among those in the Current mild asthma group compared to 
the No asthma comparison group.  This difference was statistically significant, however, the 
absolute difference in the number of illnesses was marginal (3.3 versus 3.8 illnesses, 
respectively; Table 2).  There was no clear difference between the number of illnesses 
between the Previous mild asthma and No asthma groups.  
Overall, the mean number of respiratory illnesses was similar between the three cohorts, 
with the current mild asthma group reporting slightly fewer of these presentations than the 
no asthma group (1.0 versus 1.1 respiratory illnesses respectively, p=0.04, Table 2). 
The number of restricted work days was slightly lower in the Current mild asthma and the 
Previous mild asthma groups, compared to the No asthma group.  There was no statistically 
significant difference in the number of full days off work (including hospital days) between 
the three cohorts (Table 2).   
The median cost of days in hospital per person was lower among recruits in the Current mild 
asthma group compared to the No asthma group (Table 3).  The median costs associated 
with lost productivity from both full days off work and restricted work days per person were 
also lower for the Current mild asthma cohort compared with the No asthma cohort.  The 
Previous mild asthma group had lower costs associated with hospital visits compared to the 
No asthma group. By contrast, the costs associated with full days off work and restricted 
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work days per person were not significantly different. The number of hospital days, full days 
off work and restricted duty days used to calculate the associated costs are presented in 
Supplementary Table A. 
The costs of prescription medications per person was slightly higher in the Current mild 
asthma cohort compared to the No asthma cohort (mean difference AU$24).  However, this 
difference is almost entirely explained by the costs of asthma medications prescribed to the 
Current mild asthma group as compared to the No asthma group (mean difference AU$23; 
Table 4).  Asthma medication costs were also significantly higher in the Previous mild 
asthma cohort compared to the No asthma cohort (mean difference AU$8). 
The number of discharges from the ADF within the first 12 months of service was similar 
between the Current mild asthma, Previous mild asthma and No asthma groups. The overall 
attrition rate for the whole sample was 13.5% (Table 5). 
The reasons for discharge were recorded by the Directorate of Workforce Information 
(Supplementary Table B).  For the Current mild asthma cohort, the reasons for discharged 
were reviewed to determine if asthma symptoms were an attributable cause. Thirty per 
cent of all Current mild asthma cohort discharges were listed as “Retention not in Service 
interest” and 6.7% were listed as “Medically unfit for service”.  However, it was not possible 
to ascertain specific reasons.  A subsequent review of the medical records was conducted by 
an Army Medical Officer and it was found that asthma symptoms directly contributed to the 
early discharge of 3 of the 30 cases in the Current mild asthma cohort. 
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DISCUSSION 
It is generally accepted that military service is unique compared to many other occupations, 
given the greater physical and mental stress that is involved.  There is potential for exposure 
to environmental stimuli and physical conditions that could exacerbate or re-establish 
symptoms of asthma.  However, the current study did not find evidence that recruits with 
current mild asthma symptoms experienced worse health or administrative outcomes, nor 
were they more costly, compared to recruits with no history of ever having asthma.   
Few differences were found between recruits with previous mild asthma (i.e. a history of 
asthma within the last three years, but no current asthma symptoms or asthma medication) 
and the cohort with no history of asthma ever or had no asthma symptoms within the past 
three years.   
Illness 
Recruits with Current mild asthma were not more likely than the No asthma cohort to have 
an illness.  In fact, the Current mild asthma cohort had statistically significantly fewer 
recorded illnesses compared to the No asthma cohort, although the absolute difference in 
the number of illnesses was very small.  This finding was different from a study reported in 
the US where in a Navy training centre, trainees with asthma (based on spirometry test and 
BPT) were found to use more health care during training than those without asthma [9].  
The results from the present study suggest that recruits with current mild asthma symptoms 
were not more likely to experience an illness related to asthma or any other disease or 
infection in the first 12 months after recruitment.  This may suggest that the Current mild 
asthma cohort managed their health well compared to the Previous and No asthma cohorts.  
The finding that the Current mild asthma cohort did not experience a greater number of 
illnesses compared to the No asthma cohort, and in fact had fewer illnesses, may also 
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reflect the type of individuals who are attracted to joining the military.  Through self-
selection, severe asthmatics who generally do not manage their illness well may be less 
inclined to participate in a career with such high physical demands.  Therefore, the group of 
asthmatics in the current study may have been a ‘healthier’ cohort compared to asthmatics 
in the general population.   
Absenteeism, productivity, and costs 
More frequent illness among asthma patients would increase healthcare costs and also 
affect absenteeism and productivity.  Consistent with the finding that the Current mild 
asthma cohort had fewer recorded illnesses than the other cohorts, the cohort also had 
slightly fewer restricted work days.  There were no differences between the three cohorts in 
the number of full days off work per person, including hospital days.  Following a similar 
trend, the cost of absenteeism due to hospital visits per person was lower among the 
Current mild asthma and Previous mild asthma cohorts compared to recruits with no history 
of asthma.  Costs associated with productivity loss from full days off work and restricted 
work days (i.e. 50% limited capacity) were significantly lower for the Current mild asthma 
cohort compared to the No asthma cohort.  However, there were no differences between 
the Previous mild asthma and No asthma cohorts. These results may reflect trends that 
suggest the burden of asthma has declined in recent years, including in the US military [10], 
potentially as a result of improved ongoing management of asthma.  Given that the Current 
mild asthma cohort had fewer absentee days and therefore potentially less loss of 
productivity, it is once again unclear whether this group was somehow healthier compared 
to the No asthma comparison cohort.  It may also be that the ‘less-healthy’ recruits in the 
asthma cohort discharged, therefore biasing the group towards being ‘healthy’.  However, a 
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review of recruit medical records found only three cases where asthma was listed as a 
reason for discharge.   
There was an even distribution of new recruit officers and other ranks across the three 
asthma cohorts, suggesting that differences observed in costs associated with absenteeism 
and hospital days were associated with the asthma classification (i.e. Current mild asthma 
versus No asthma) and not different costs (i.e. pay level) associated with rank.  
The median cost of prescription medications between the three cohorts did not differ 
significantly.  However, taking into account the specific cost of asthma medication, there 
were greater costs associated with the Current mild asthma cohort.  What is important is 
that the associated difference was small, with a median difference of only AU$23 per person 
between the No asthma and Current mild asthma cohorts.  The Previous mild asthma cohort 
also had a significantly higher cost of asthma prescription medication compared to No 
asthma recruits; however the median difference cost was only AU$8 over the course of 12 
months.  Therefore, mild asthmatic recruits and recruits with previous mild asthma were 
not found to cost the military a great deal of money to manage their condition.  Taken 
together with the lower frequency of illnesses and associated costs, as well as fewer 
hospitalisations and days off, the overall cost of recruiting personnel with mild current 
asthma symptoms to the military appears to be negligible. 
Administrative outcomes:  attrition 
Illness, disability, attrition, and discharge are costly and may influence military readiness.  
Recruiting training programs, both in Australia and internationally, typically report high 
attrition rates [11].  Reasons for failure include injury or illness, self-requested discharge, 
and poor psychological suitability [12].  A cohort study found that out of 1,317 recruits 
undertaking a 12-week basic training course at Army Recruit Training Centre, 184 were 
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discharged (14% attrition rate) and most were discharged as ‘medically unfit’ (59%) [13].  In 
another study on ADF recruits, an attrition rate of 17% was found [14]. The current study 
builds on the findings of previous research on recruit attrition rates in Australia.  The overall 
attrition rate of recruits in the current study was 13.5% over 12 months, which is similar to 
the earlier research finding.  The attrition rates were very similar across the three cohorts. 
The greatest discharge of recruits occurred in the Current mild asthma and No asthma 
cohorts in the first three months (7% and 8% attrition, respectively).  Whilst the attrition 
rates of the Current and Previous mild asthma cohorts were well within the usual range for 
recruits separating in their first year [13 14], it was not clear from the administrative records 
whether asthma symptoms directly contributed to these early discharges in any of the 
cohorts.  When medical records were individually examined for the Current mild asthma 
cohort, asthma was only directly attributed as the reason for discharge in three out of 30 
cases.  It would be helpful for future surveillance studies if reasons for separation by recruits 
with asthma were collected by the ADF to allow for a detailed analysis of specific medical 
discharges to be made.   
A number of other studies have also found that attrition rates are greater in the first months 
of training for recruits with mild asthma [9 15 16].  In the current study, whilst this rate was 
higher for early attrition (i.e. within 90 days of enlistment) for new recruits with mild 
asthma, it was not different from recruits with no history of asthma.  In a study conducted 
at a US Navy centre, 136 mild asthmatics were compared with 404 controls.  Attrition was 
greater among the asthma cohort (p < 0.01), particularly during the first two to three 
months (odds ratio 7.72; confidence interval 4.79 – 12.45).  After the completion of basic 
training, however, the discharge rates in the asthma cohort decreased considerably (odds 
ratio 1.6, confidence interval 0.98 – 2.67) [9].   
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The results of a number of other studies have been mixed. Clarke showed no clear 
difference in overall discharge rates between those with asthma (classified on initial medical 
examination) and controls [15]. Others have found that although asthmatics may be more 
likely to discharge during the recruitment phase, afterwards, retention may actually be 
greater [16 17].  
Direction for future research 
Several issues arising in the current study warrant further investigation.  First, this study 
highlights some of the short-term outcomes of accepting mild asthmatic recruits into the 
military.  In particular, recruits with current mild asthma did not have worse health or 
administrative outcomes nor were they more costly.  However, this finding does not take 
into account the long-term outcomes of these recruits as they progress in their military 
career.  Many of the unique characteristics of the military that could exacerbate asthma 
may not be encountered until such time as the individual deploys, at which time they could 
be exposed, for example, to chemical or biological agents, emotional stress from being in a 
hostile, or an unpredictable environment [3 18].  Respiratory symptoms in self-reported 
asthmatics and non-asthmatics have been shown to increase from pre-deployment levels 
whilst in the Middle East [19].  ADF members deployed to Afghanistan and Iraq have also 
reported exposures to a number of smoke, dust and chemical exposures which were 
associated with poorer subsequent respiratory health [20].  Exposure to a new allergen for 
the first time may have negative unforeseen circumstances, whilst prolonged exposure to 
allergens and/or stressors may tip a person over the threshold at which the problem is 
manageable.  There is also evidence that military personnel with asthma may have high 
rates of job transfer and downgrading, particularly out of combat units [15 21 22]. 
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Longitudinal follow-up of recruits with mild asthma and a history of previous asthma is 
necessary.  The current study did not assess in detail the specific roles, responsibilities and 
exposures encountered in the first year of service in each cohort.  Such information would 
be useful to examine in detail any patterns of increased health care use and discharge rates 
among those with mild or previous asthma.  In particular, it will be important to ascertain if 
there are longer-term administrative outcomes for mild asthmatics which may impact on 
military readiness and capability.  Additionally, further studies which assessed the 
respiratory exposures and outcomes of mild asthmatics who deploy to overseas to areas 
where they are likely to encounter specific respiratory exposures would be valuable.  There 
may be some important information that could be obtained that could influence policy 
about the types of jobs that may be most suited to personnel with current mild asthma or a 
history of mild asthma that is not currently being medically treated.   
It may have been possible for a small number of members of the ‘no asthma’ group to have 
concealed symptoms for fear of exclusion from the recruitment process.  Studies which also 
conducted respiratory testing on the control groups would be less susceptible to this type of 
bias. 
Conclusion 
In summary, the present study demonstrated that the adoption of the revised recruitment 
standards for the inclusion of mild asthmatics who are taking low dose asthma medication 
in the ADF has not resulted in unanticipated medical or administrative costs to the 
organisation.  Young men and women entering the military with current mild asthma 
symptoms that were being medically managed were not found to be at greater risk for 
being ill, did not require more time off work (full or restricted duty days), nor did they incur 
greater costs associated with hospitalisations.  They did, however, have slightly greater 
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prescription medication costs associated with mild asthma, although the overall cost per 
person was found to be low.  The study suggests that recruits with current mild asthma may 
have managed their health well.  Overall, the findings from this study support the changes 
made by the ADF to the recruitment standards for mild asthmatics.  Follow up is required to 
assess the long-term health and administrative outcomes of this group of recruits with mild 
asthma. 
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